Eucrates Biomedical Acquisition Corp. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EUCRW and buy or sell other stocks, ETFs, and their options commission-free!About EUCRW
Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.
CEOParag Phoolchand Saxena, MBA
CEOParag Phoolchand Saxena, MBA
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2020
Founded2020
Employees—
Employees—
EUCRW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume10.76K
Average volume10.76K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.28
52 Week high$0.28
52 Week low$0.0018
52 Week low$0.0018
Stock Snapshot
As of today, Eucrates Biomedical Acquisition Corp. Warrant(EUCRW) shares are valued at $0.00.
Eucrates Biomedical Acquisition Corp. Warrant(EUCRW) stock opened on 2025-12-18 at —. The price climbed to — and dipped to —.
Eucrates Biomedical Acquisition Corp. Warrant(EUCRW) shares are trading with a volume of 0, against a daily average of 10.76K.
In the last year, Eucrates Biomedical Acquisition Corp. Warrant(EUCRW) shares hit a 52-week high of $0.28 and a 52-week low of $0.00.
In the last year, Eucrates Biomedical Acquisition Corp. Warrant(EUCRW) shares hit a 52-week high of $0.28 and a 52-week low of $0.00.